ResearcherUniversity of California, San FranciscoNo recent work listed
Suprit Gupta
Matched on ORCID iD 0000-0002-5861-9944; OpenAlex author ID A5010427688. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 6
- Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215801↗
- Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth. Co-author DOI 10.1038/s41556-021-00644-7↗
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Co-author DOI 10.1038/s41586-020-2229-5↗
- MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Co-author DOI 10.18632/genesandcancer.104↗
- Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3912↗
- Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Co-author DOI 10.1016/j.canlet.2013.07.037↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 4 shared papers, 2013–2022 · strength 0.28
- Paper Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. DOI 10.1016/j.canlet.2022.215801↗
- Paper MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mecha… DOI 10.18632/genesandcancer.104↗
- Paper Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. DOI 10.18632/oncotarget.3912↗
- Satyanarayana Rachagani · 4 shared papers, 2013–2022 · strength 0.28
- Paper Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. DOI 10.1016/j.canlet.2022.215801↗
- Paper MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mecha… DOI 10.18632/genesandcancer.104↗
- Paper Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. DOI 10.18632/oncotarget.3912↗
- Maneesh Jain · 3 shared papers, 2013–2022 · strength 0.22
- Paper Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. DOI 10.1016/j.canlet.2022.215801↗
- Paper Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. DOI 10.18632/oncotarget.3912↗
- Paper Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src… DOI 10.1016/j.canlet.2013.07.037↗
- Grace Kim · 2 shared papers, 2020–2021 · strength 0.20
- Rushika Miriam Perera · 2 shared papers, 2020–2021 · strength 0.20
- Moorthy Palanimuthu Ponnusamy · 3 shared papers, 2013–2016 · strength 0.14
- Paper MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mecha… DOI 10.18632/genesandcancer.104↗
- Paper Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. DOI 10.18632/oncotarget.3912↗
- Paper Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src… DOI 10.1016/j.canlet.2013.07.037↗
- Jesse L. Cox · 1 shared paper, 2022 · strength 0.13
- Shailendra Kumar Gautam · 1 shared paper, 2022 · strength 0.13
- Vincent M. Chung · 1 shared paper, 2022 · strength 0.13
- Ravi Salgia · 1 shared paper, 2022 · strength 0.13
- Roberto Zoncu · 1 shared paper, 2021 · strength 0.11
- Gilles Rademaker · 1 shared paper, 2021 · strength 0.11
- David W. Dawson · 1 shared paper, 2021 · strength 0.11
- Parthasarathy Seshacharyulu · 2 shared papers, 2015–2016 · strength 0.10
- Dhanya Haridas · 2 shared papers, 2015–2016 · strength 0.10
- Imayavaramban Lakshmanan · 2 shared papers, 2015–2016 · strength 0.10
- Anthony C. Venida · 1 shared paper, 2020 · strength 0.09
- Douglas E. Biancur · 1 shared paper, 2020 · strength 0.09
- Seth J. Parker · 1 shared paper, 2020 · strength 0.09
- Joao A Paulo · 1 shared paper, 2020 · strength 0.09
- Keisuke Yamamoto · 1 shared paper, 2020 · strength 0.09
- Subhadip Mukhopadhyay · 1 shared paper, 2020 · strength 0.09
- Douglas T. Fearon · 1 shared paper, 2020 · strength 0.09
- Robert Singhung Banh · 1 shared paper, 2020 · strength 0.09
- Elaine Y. Lin · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.